Logo image of EGIO

EDGIO INC (EGIO) Stock Fundamental Analysis

NASDAQ:EGIO - Nasdaq - US53261M2035 - Common Stock - Currency: USD

1.11  -0.27 (-19.57%)

After market: 1.0496 -0.06 (-5.44%)

Fundamental Rating

2

Overall EGIO gets a fundamental rating of 2 out of 10. We evaluated EGIO against 82 industry peers in the IT Services industry. EGIO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EGIO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EGIO had negative earnings in the past year.
In the past year EGIO has reported a negative cash flow from operations.
EGIO had negative earnings in 4 of the past 5 years.
EGIO had a positive operating cash flow in 4 of the past 5 years.
EGIO Yearly Net Income VS EBIT VS OCF VS FCFEGIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -50M -100M

1.2 Ratios

EGIO has a Return On Assets of -33.85%. This is amonst the worse of the industry: EGIO underperforms 86.75% of its industry peers.
EGIO has a Return On Equity of -99.89%. This is in the lower half of the industry: EGIO underperforms 74.70% of its industry peers.
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A
EGIO Yearly ROA, ROE, ROICEGIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 29.13%, EGIO is doing worse than 66.27% of the companies in the same industry.
In the last couple of years the Gross Margin of EGIO has declined.
EGIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%
EGIO Yearly Profit, Operating, Gross MarginsEGIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

EGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
EGIO has more shares outstanding than it did 1 year ago.
EGIO has a better debt/assets ratio than last year.
EGIO Yearly Shares OutstandingEGIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
EGIO Yearly Total Debt VS Total AssetsEGIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

EGIO has an Altman-Z score of -2.18. This is a bad value and indicates that EGIO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EGIO (-2.18) is worse than 86.75% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that EGIO is somewhat dependend on debt financing.
EGIO has a Debt to Equity ratio of 0.89. This is in the lower half of the industry: EGIO underperforms 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC3.38%
EGIO Yearly LT Debt VS Equity VS FCFEGIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.85 indicates that EGIO may have some problems paying its short term obligations.
The Current ratio of EGIO (0.85) is worse than 79.52% of its industry peers.
EGIO has a Quick Ratio of 0.85. This is a bad value and indicates that EGIO is not financially healthy enough and could expect problems in meeting its short term obligations.
EGIO has a worse Quick ratio (0.85) than 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
EGIO Yearly Current Assets VS Current LiabilitesEGIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

EGIO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33866.67%.
The Revenue has grown by 37.59% in the past year. This is a very strong growth!
EGIO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.93% yearly.
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%

3.2 Future

EGIO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 118.32% yearly.
Based on estimates for the next years, EGIO will show a quite strong growth in Revenue. The Revenue will grow by 9.99% on average per year.
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EGIO Yearly Revenue VS EstimatesEGIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EGIO Yearly EPS VS EstimatesEGIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5 10 -10 15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EGIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EGIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EGIO Price Earnings VS Forward Price EarningsEGIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EGIO Per share dataEGIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

EGIO's earnings are expected to grow with 106.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-390.68%
EPS Next 3Y106.46%

More info and screens

0

5. Dividend

5.1 Amount

EGIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDGIO INC

NASDAQ:EGIO (9/17/2024, 8:02:28 PM)

After market: 1.0496 -0.06 (-5.44%)

1.11

-0.27 (-19.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-25 2024-04-25/amc
Earnings (Next)10-17 2024-10-17/amc
Inst Owners0.02%
Inst Owner Change-2.63%
Ins Owners118.55%
Ins Owner Change0%
Market Cap6.50M
Analysts45.71
Price Target30.6 (2656.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.92%
Min EPS beat(2)2.79%
Max EPS beat(2)19.05%
EPS beat(4)3
Avg EPS beat(4)-12.91%
Min EPS beat(4)-90.08%
Max EPS beat(4)19.05%
EPS beat(8)5
Avg EPS beat(8)31.31%
EPS beat(12)5
Avg EPS beat(12)-26.93%
EPS beat(16)8
Avg EPS beat(16)-1.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.58%
Min Revenue beat(4)-23.22%
Max Revenue beat(4)-0.42%
Revenue beat(8)0
Avg Revenue beat(8)-8.58%
Revenue beat(12)0
Avg Revenue beat(12)-8.9%
Revenue beat(16)2
Avg Revenue beat(16)-6.58%
PT rev (1m)34.33%
PT rev (3m)34.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)0%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.19
EYN/A
EPS(NY)-5.78
Fwd EYN/A
FCF(TTM)-8.69
FCFYN/A
OCF(TTM)-6.65
OCFYN/A
SpS64.83
BVpS26.21
TBVpS-15.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.13%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%
F-Score2
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.49%
Cap/Sales 3.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z -2.18
F-Score2
WACC3.38%
ROIC/WACCN/A
Cap/Depr(3y)94.14%
Cap/Depr(5y)108.41%
Cap/Sales(3y)11.25%
Cap/Sales(5y)11.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%
EBIT growth 1Y-75.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.19%
EBIT Next 3Y40.08%
EBIT Next 5Y32.04%
FCF growth 1Y-113.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.67%
OCF growth 3YN/A
OCF growth 5YN/A